TTK Healthcare Limited Approves Rs 706.52 Crore Bonus Issue
Key highlights
- TTK Healthcare approved a proposed Rs 706.52 crore bonus NCRPS issue on November 20, 2026.
- Shareholders would receive 5 NCRPS of Rs 100 each for every 1 equity share held on the record date.
- The proposed NCRPS carry a 9.5% annual dividend and mature 15 months after allotment.
- TTK Healthcare reported Rs 1,301.34 crore in general reserves and retained earnings as of September 30, 2026.
powered by IRIS

TTK Healthcare Limited approved on November 20, 2026 a proposed issue of 7,06,51,665 non-convertible redeemable preference shares worth Rs 706.52 crore, giving five shares for every equity share held on the record date. The proposed 15-month shares carry a 9.5% annual dividend and require specified approvals.
Know TTK Healthcare inside out
Results, valuation, peers and who's buying, in one view.
What did TTK Healthcare approve on November 20, 2026?
TTK Healthcare approved a Scheme of Arrangement under Section 230 of the Companies Act, 2013, to allot Non-Convertible Redeemable Preference Shares, or NCRPS, as a bonus to equity shareholders. The board meeting on November 20, 2026 began at 12 noon and ended at 12.20 p.m., after which the company disclosed the decision to BSE Limited and the National Stock Exchange of India Limited.
The proposed issue comprises 7,06,51,665 NCRPS with a face value and issue price of Rs 100 each, aggregating to Rs 706.52 crore. The NCRPS will not convert into equity shares, and TTK Healthcare said the issue will not change its existing equity-share count.
The arrangement remains subject to statutory, regulatory and customary approvals. TTK Healthcare specifically identified approvals from the stock exchanges, the jurisdictional National Company Law Tribunal, or NCLT, and shareholders and creditors, as applicable.
How many preference shares will TTK Healthcare shareholders receive?
TTK Healthcare proposes to issue five fully paid NCRPS of Rs 100 each for every one fully paid equity share of Rs 10 held on the record date. The company had not disclosed a record date in its November 20, 2026 announcement, and the actual number of NCRPS will be determined by outstanding equity capital on that date.
Based on the November 20, 2026 equity base of 1,41,30,333 issued, subscribed and paid-up equity shares, the five-for-one ratio produces the announced 7,06,51,665 NCRPS. At the Rs 100 face value, that calculation gives an estimated issue size of Rs 706.52 crore.
The comparison shows that paid-up capital would rise by Rs 706.52 crore through the preference-share allotment while the equity-share count remains unchanged. Based on the same November 20 figures, authorised capital would increase from Rs 20 crore to Rs 750 crore, including authorisation for 7,30,00,000 NCRPS.
What dividend and redemption terms apply to TTK Healthcare NCRPS?
TTK Healthcare's proposed NCRPS carry a dividend rate of 9.5% per annum and a tenure of 15 months from allotment. The company plans to redeem the shares at par, or Rs 100 per NCRPS, at the end of that tenure or earlier if the board chooses to exercise its option.
The first dividend will accrue from the allotment date to March 31 of the financial year in which the NCRPS are allotted. Thereafter, dividend will accrue on March 31 of each financial year; in the year of redemption, it will accrue proportionately from April 1 until redemption and be payable with the redemption amount.
No dividend will accrue after redemption, under the disclosed terms. TTK Healthcare also stated that no charge or security will be created over its assets for the NCRPS and that the instrument carries no special rights, interests or privileges.
TTK Healthcare proposes to list the bonus NCRPS on BSE and NSE, where its equity shares are already listed. The listing remains proposed and depends on the approvals under the scheme and the applicable exchange process.
Got a follow-up? Ask IRIS
How will TTK Healthcare fund the bonus issue and redemption?
TTK Healthcare proposes to use general reserves and/or retained earnings for the estimated Rs 706.52 crore bonus issue. The actual amount used may differ because the company will calculate the final NCRPS allotment using total equity shares outstanding on the record date.
As of September 30, 2026, TTK Healthcare reported general reserves of Rs 78.48 crore and retained earnings of Rs 1,222.86 crore, totalling Rs 1,301.34 crore. The company said these figures were drawn from limited reviewed financial results for the quarter and half-year ended September 30, 2026, reviewed by its statutory auditors.
For redemption, TTK Healthcare said it will use general reserves and/or retained profits. The stated maturity is 15 months after allotment, but the board may redeem earlier, leaving the final redemption date dependent on both allotment and any decision to exercise that option.
When will TTK Healthcare allot and list the bonus NCRPS?
TTK Healthcare will allot the bonus NCRPS after NCLT approval of the scheme to shareholders holding equity shares on the record date. The November 20, 2026 filing does not specify a calendar date for the NCLT process, record date, allotment or proposed BSE and NSE listing.
The issue is therefore at the board-approval stage despite the disclosed estimate of 7,06,51,665 NCRPS. The announced five-NCRPS-per-equity-share ratio will apply to eligible holders on the record date, while the final quantum will reflect equity capital then outstanding.
Conclusion
TTK Healthcare's proposal would give equity shareholders a 15-month preference instrument carrying a 9.5% annual dividend, with an estimated value of Rs 706.52 crore. The arrangement would use general reserves and/or retained earnings, preserve the existing equity-share count and provide for redemption at Rs 100 per NCRPS.
The next disclosed milestones are approvals from stock exchanges, the NCLT, shareholders and creditors where applicable, followed by the record date and allotment. TTK Healthcare has proposed BSE and NSE listing, while its board retains the option to redeem the NCRPS before the scheduled 15-month maturity.


